US Stock MarketDetailed Quotes
BIIB Biogen
Watchlist
300.200
-2.210-0.73% Close 06/02 16:00 ET
300.750+0.550+0.18%
Post 18:05 ET
303.170High297.680Low817.15KVolume
302.530Open302.410Pre Close245.43MTurnover0.57%Turnover Ratio13.98P/E (TTM)43.45BMarket Cap319.74052wk High14.38P/E (Static)144.74MShares188.53552wk Low3.15P/B43.33BFloat Cap480.180Historical High--Dividend TTM144.32MShs Float2.625Historical Low--Div YieldTTM1.82%Amplitude300.348Avg Price1Lot Size
Quarterly+Annual
Quarterly+Annual
Annual
Quarterly
Cumulative Quarterly
YOY
Hide blank lines
(Q1)2023/03/31(FY)2022/12/31(Q4)2022/12/31(Q3)2022/09/30(Q2)2022/06/30(Q1)2022/03/31(FY)2021/12/31(Q4)2021/12/31(Q3)2021/09/30(Q2)2021/06/30
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
181.40%455.3M-61.97%1.38B-120.88%-175M-17.92%661M-39.99%736.5M-78.96%161.8M-13.95%3.64B328.36%838.3M-31.82%805.3M-37.01%1.23B
Net income from continuing operations
77.39%387.6M71.43%2.96B2,780.49%549.5M256.89%1.13B3.24%1.06B-46.00%218.5M-57.45%1.73B-105.73%-20.5M-54.82%318M-36.16%1.03B
Operating gains losses
-59.05%79.6M-320.46%-1.75B7.10%105.6M-243.89%-612.7M-661.07%-1.43B-57.35%194.4M201.84%791.9M111.82%98.6M334.93%425.8M-56.66%-188.3M
Depreciation and amortization
-21.52%112.3M6.29%518.4M-11.06%119.8M-9.38%120.7M15.02%134.8M39.47%143.1M6.67%487.7M22.79%134.7M16.13%133.2M3.81%117.2M
Deferred tax
-6,550.00%-64.5M60.50%-168.6M-108.91%-28.8M27.49%-92.3M92.02%-48.5M106.67%1M-386.44%-426.8M613.99%323.3M-501.58%-127.3M-524.15%-607.8M
Other non cash items
-84.64%48.8M-0.53%335.3M-172.01%-120.4M-32.19%49.5M50.00%88.5M738.26%317.7M181.15%337.1M500.96%167.2M2,907.69%73M-9.09%59M
Change In working capital
76.41%-184.1M-511.89%-890.3M-1,395.93%-987.5M97.68%-2.7M289.56%880.4M-135.66%-780.5M22.28%-145.5M156.40%76.2M-163.77%-116.5M142.75%226M
-Change in receivables
277.71%114.8M-168.22%-222.4M-171.04%-109.9M31.43%-21.6M-121.59%-26.3M-179.75%-64.6M81.62%326M-38.66%154.7M-167.02%-31.5M203.74%121.8M
-Change in inventory
119.57%27.9M30.75%-320.2M112.95%18.1M26.24%-95M-23.86%-100.7M-26.76%-142.6M-46.19%-462.4M-205.91%-139.8M-56.31%-128.8M35.48%-81.3M
-Change in payables and accrued expense
36.09%-295M-18.87%-113.4M-604.19%-745.7M96.90%-1.7M1,050.84%1.1B-62.76%-461.6M-161.87%-95.4M167.63%147.9M-106.74%-54.9M201.28%95.2M
-Change in other working capital
71.53%-31.8M-371.49%-234.3M-73.21%-150M17.12%115.6M-197.67%-88.2M-593.79%-111.7M142.18%86.3M29.54%-86.6M116.55%98.7M-66.92%90.3M
Cash from discontinued investing activities
Operating cash flow
181.40%455.3M-61.97%1.38B-120.88%-175M-17.92%661M-39.99%736.5M-78.96%161.8M-13.95%3.64B328.36%838.3M-31.82%805.3M-37.01%1.23B
Investing cash flow
Cash flow from continuing investing activities
-47.07%-953M379.69%1.58B-25.20%-141.1M815.84%1.67B554.16%693.5M-901.55%-648M7.38%-563.7M32.27%-112.7M-345.80%-233.6M81.66%-152.7M
Net PPE purchase and sale
-15.03%-66.6M232.62%342.3M-67.44%-86.4M1,346.43%523.5M48.68%-36.9M37.47%-57.9M39.24%-258.1M40.00%-51.6M50.06%-42M31.52%-71.9M
Net intangibles purchase and sale
---5M92.12%-2.9M94.08%-1M--0---1.9M--071.02%-36.8M-12.67%-16.9M---19.9M----
Net business purchase and sale
----3,424.20%990.3M--0--0--------102.79%28.1M--0--0--0
Net investment purchase and sale
-49.30%-880.7M171.82%222.5M-35.04%-76.3M774.63%1.15B-224.84%-260.2M-20,241.38%-589.9M-131.72%-309.8M-114.69%-56.5M-136.58%-170.3M86.16%-80.1M
Net other investing changes
-250.00%-700K89.15%24.4M83.74%22.6M85.71%-200K414.29%2.2M-107.41%-200K147.96%12.9M238.20%12.3M86.27%-1.4M90.41%-700K
Cash from discontinued investing activities
Investing cash flow
-47.07%-953M379.69%1.58B-25.20%-141.1M815.84%1.67B554.16%693.5M-901.55%-648M7.38%-563.7M32.27%-112.7M-345.80%-233.6M81.66%-152.7M
Financing cash flow
Cash flow from continuing financing activities
-163.03%-43.4M16.24%-1.75B-175.51%-7.4M-67.70%-1.25B16.47%-471.5M97.90%-16.5M60.43%-2.09B102.44%9.8M43.14%-746.5M57.02%-564.5M
Net issuance payments of debt
-----489.53%-1B--0---1B---------111.59%-170M--0--0-100.05%-700K
Net common stock issuance
----58.33%-750M--066.67%-250M--------73.05%-1.8B--040.00%-750M83.98%-450M
Proceeds from stock option exercised by employees
-188.94%-60.1M-171.43%-1.9M-48.68%3.9M-3.39%5.7M-27.91%9.3M23.25%-20.8M84.78%-700K5.56%7.6M-20.27%5.9M24.04%12.9M
Net other financing activities
288.37%16.7M105.89%6.8M-613.64%-11.3M-125.00%-5.4M115.15%19.2M-62.28%4.3M-104.79%-115.5M126.19%2.2M96.59%-2.4M-811.80%-126.7M
Cash from discontinued financing activities
Financing cash flow
-163.03%-43.4M16.24%-1.75B-175.51%-7.4M-67.70%-1.25B16.47%-471.5M97.90%-16.5M60.43%-2.09B102.44%9.8M43.14%-746.5M57.02%-564.5M
Net cash flow
Beginning cash position
51.20%3.42B69.88%2.26B138.40%3.68B51.93%2.65B43.68%1.75B69.88%2.26B-54.31%1.33B-30.70%1.54B-26.96%1.74B-53.02%1.22B
Current changes in cash
-7.64%-541.1M22.59%1.21B-143.99%-323.5M718.59%1.08B87.90%958.5M-522.92%-502.7M159.95%990M178.69%735.4M5.10%-174.8M358.15%510.1M
Effect of exchange rate changes
312.77%20M6.86%-55.7M525.32%67.2M-105.91%-52.3M-525.00%-61.2M71.52%-9.4M-186.67%-59.8M-138.54%-15.8M-205.39%-25.4M263.64%14.4M
End cash Position
65.68%2.9B51.20%3.42B51.20%3.42B138.40%3.68B51.93%2.65B43.68%1.75B69.88%2.26B69.88%2.26B-30.70%1.54B-26.96%1.74B
Free cash flow
269.30%383.7M-65.89%1.14B-134.09%-262.4M-19.03%601.9M-39.61%697.7M-84.64%103.9M-9.05%3.35B264.45%769.8M-32.23%743.4M-37.33%1.16B
Currency Unit
USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions
--Unqualified Opinion--------Unqualified Opinion------
Paper Trade
Start
No data yet
Symbol
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Order Type Description
LMT Order
Odd Lot Order
Enhanced limit orders can be placed at a specified price. Trading hours: 09:30-12:00 & 13:00-16:00, excluding Saturdays, Sundays, and public holidays.
Order Details
Account
Types
LMT Order
Direction
Name
Price
QTY
Shares
Amount
--
Cancel
Confirm
Confirm